Zimmer Biomet Holdings, Inc. Stock Xetra

Equities

ZIM

US98956P1021

Medical Equipment, Supplies & Distribution

Delayed Xetra 11:35:56 2022-08-12 EDT 5-day change 1st Jan Change
113.3 EUR +0.87% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% -.--%

Financials

Sales 2024 * 7.76B 7.16B 10.58B Sales 2025 * 8.12B 7.49B 11.06B Capitalization 23.69B 21.84B 32.28B
Net income 2024 * 986M 909M 1.34B Net income 2025 * 1.19B 1.09B 1.62B EV / Sales 2024 * 3.61 x
Net Debt 2024 * 4.34B 4B 5.91B Net Debt 2025 * 3.03B 2.8B 4.13B EV / Sales 2025 * 3.29 x
P/E ratio 2024 *
23.6 x
P/E ratio 2025 *
20.4 x
Employees 18,000
Yield 2024 *
0.84%
Yield 2025 *
0.85%
Free-Float 64.77%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Zimmer Biomet Holdings, Inc.

3 years
95.40
Extreme 95.4
139.20
5 years
83.50
Extreme 83.5
150.00
10 years
83.50
Extreme 83.5
150.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 18-10-31
Director of Finance/CFO 55 19-06-30
Chief Tech/Sci/R&D Officer - 21-06-06
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 68 08-12-31
Director/Board Member 51 14-12-11
More insiders
Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
115.2 USD
Average target price
136.4 USD
Spread / Average Target
+18.42%
Consensus